Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today: Vanda Pharmaceuticals Inc. VNDA: This biopharmaceutical company has seen the Zacks Consensus Estimate for its current year ...
SHOP's third-quarter 2024 results reflect a booming merchant base, expanding partnerships, and robust revenue growth.
The semiconductor manufacturing equipment specialist reported record revenues in its fiscal 2024 fourth quarter.
Zacks.com on MSN19h
CocaCola Company (The) (KO) is Attracting Investor Attention: Here is What You Should KnowCoca-Cola (KO) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Tower Semiconductor Ltd (NASDAQ: TSEM) reported a fiscal third-quarter 2024 revenue growth of 3.4% year-on-year to $370.51 ...
Zacks.com on MSN6h
Lyell Immunopharma (LYEL) Upgraded to Buy: Here's What You Should KnowLyell Immunopharma (LYEL) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is one ...
EVgo Inc (NASDAQ:EVGO) shares are trading higher after the company reported third-quarter sales growth of 92% year-on-year to ...
Zacks.com on MSN6h
Northrim (NRIM) Upgraded to Strong Buy: Here's What You Should KnowNorthrim BanCorp (NRIM) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting ...
It reported adjusted earnings of $2.93 per share, beating the Zacks Consensus Estimate of $2.87. The bottom line, however, declined from $3.04 recorded in the year-ago period. Consolidated net ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback